Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Chin J Integr Med ; 23(11): 850-857, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28755077

RESUMEN

OBJECTIVE: To determine the pyrolysis characteristics of calcined and processed calamine, qualitatively and quantitatively compare the contents of related elements, morphology and functional groups of the pyrolysis products dried at different heating temperatures and explore the critical temperature and the optimal drying temperature for the process of calamine with Huanglian Decoction (HLD, ) and San Huang Decoction (SHD, ). METHODS: Pyrolysis products were prepared by programmable and constantly heating the calcined and processed calamine to or at different heating temperatures. Thermogravimetry (TG) was used to test their pyrolysis characteristics. Fourier transform infrared spectroscopy and scanning electron microscopeenergy dispersive spectrometer were used to determine their morphology, functional groups and element contents. Page model was used to investigate the constant drying kinetics of processed calamine. RESULTS: The adding of HLD or SHD to calcined calamine (CC) can slow its weight loss in drying pyrolysis process. The temperature ranges where HLD and SHD can affect its weight loss were 65-150 °C and 74-180 °C, respectively. The drying temperature was optimized as 90 °C. The drying kinetic for the processed calamine fits Page model shows good linearity. CONCLUSIONS: Conclusions: The critical temperature and the optimal drying temperature where HLD and SHD can affect the weight loss rate in the process of calamine were explored using the theories and methods of both biophysical chemistry and processing of Chinese materia medica. This work provides a good example for the study of the process of other Chinese medicines using modern analytical techniques.


Asunto(s)
Técnicas de Química Analítica/métodos , Medicamentos Herbarios Chinos/análisis , Compuestos Férricos/análisis , Óxido de Zinc/análisis , Combinación de Medicamentos , Cinética , Espectrometría por Rayos X , Espectroscopía Infrarroja por Transformada de Fourier , Temperatura , Termogravimetría
2.
Biochim Biophys Acta ; 1823(2): 505-13, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22192444

RESUMEN

Kv1.3 channels play an important role in modulating lymphocyte proliferation and apoptosis. We hypothesized that Kv1.3 channels in B lymphocytes might be regulated by rituximab, an antibody to CD20, a drug for treatments of B-cell lymphomas and autoimmune diseases. Using both whole-cell and cell-attached patch-clamp techniques, we found that rituximab inhibited Kv1.3 channels in Daudi human B lymphoma cells by promoting the channel inactivation at a concentration which was much greater than that required for activation of CD20. The effect of rituximab on Kv1.3 channels was abolished after selective blockade of FcγRIIB receptors with anti-FcγRIIB antibody. Western blot experiments showed that Daudi B cells expressed both Kv1.3 channel and the low affinity Fc receptor, FcγRIIB, which could be activated by the Fc region of rituximab. In contrast, normal lymphocytes expressed less Kv1.3 channels with faster inactivation. Confocal microscopy and flow cytometry data showed that rituximab induced apoptosis of Daudi B cells and that the effect was attenuated by blockade of FcγRIIB receptors and partially mimicked by inhibition of Kv1.3 channels. These results suggest that in addition to previously described complement-dependent cytotoxicity, rituximab also induces apoptosis of malignant B lymphocyte by stimulating FcγRIIB receptors and inhibiting Kv1.3 channels.


Asunto(s)
Anticuerpos Monoclonales de Origen Murino/metabolismo , Antineoplásicos/metabolismo , Canal de Potasio Kv1.3/metabolismo , Linfoma de Células B/metabolismo , Receptores de IgG/metabolismo , Adyuvantes Inmunológicos/metabolismo , Animales , Línea Celular Tumoral , Toxina del Cólera , Humanos , Linfoma de Células B/patología , Ratones , Técnicas de Placa-Clamp , Bloqueadores de los Canales de Potasio/metabolismo , Quinina/metabolismo , Rituximab
3.
Zhongguo Zhong Yao Za Zhi ; 33(23): 2820-2, 2008 Dec.
Artículo en Chino | MEDLINE | ID: mdl-19260321

RESUMEN

OBJECTIVE: The pulmonary toxicity of water extract of Siegesbeckia pubescens has been studied an mice following subchronic oral administration route. METHOD: Mice were randomly grouped and administered with the water extract of S. pubescens at dosages of 3.0, 1.0, 0.3 g x kg(-1) and saline respectively. 10 mice of each group were sacrificed on the day of 7 th, 14 th, 21 th, and 2 weeks after stopping administration, histological changes of the lung were examined. RESULT: The water extract of S. pubescens at dosage of 3.0 g x kg(-1) increased the lung index on the of day 14 th and 21 th, significant histopathological damages were observed. The histopathological changes were disappeared after stopping administration for 2 weeks. CONCLUSION: The water extract of S. pubescens has a pulmonary toxic effect on mice, and the toxic effect is reversible.


Asunto(s)
Asteraceae/química , Medicamentos Herbarios Chinos/toxicidad , Pulmón/efectos de los fármacos , Administración Oral , Animales , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/química , Femenino , Masculino , Ratones , Distribución Aleatoria
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA